Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-04 3:33 pm Unchanged | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 2,051,689 4.190% | 0 (Unchanged) | View |
| 2024-11-04 2:10 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 2,051,689 4.190% | -1,437,573 (-41.20%) | View |
| 2024-10-24 4:44 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | 3,728,382 7.600% | 3,728,382 (New Position) | View | |
| 2024-09-09 5:42 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | BAUPOST GROUP LLC | 0 0.000% | -2,977,304 (Position Closed) | View |
| 2024-08-16 4:05 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Newtyn Management LLC | 4,100,000 8.400% | 4,100,000 (New Position) | View |
| 2024-08-09 4:14 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | BAUPOST GROUP LLC | 2,977,304 6.120% | -4,441,922 (-59.87%) | View |
| 2024-06-11 4:17 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | ODRE 2005 SLU | 0 0.000% | -4,108,318 (Position Closed) | View |
| 2024-05-03 5:49 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Madison Avenue Partners LP | 8,511,350 17.500% | 1,499,124 (+21.38%) | View |
| 2024-03-05 09:01 am Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 15.500% | 0 (Unchanged) | View |
| 2024-02-14 4:00 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Irenic Capital Management LP | 2,760,948 5.500% | 2,760,948 (New Position) | View |
| 2024-02-13 5:15 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | VANGUARD GROUP INC | 3,489,262 7.010% | -2,069,577 (-37.23%) | View |
| 2024-02-08 4:54 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 4,584,596 9.200% | -745,234 (-13.98%) | View |
| 2023-08-14 5:05 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 14.120% | 0 (Unchanged) | View |
| 2023-07-10 4:33 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | BAUPOST GROUP LLC | 7,419,226 12.840% | -4,000,000 (-35.03%) | View |
| 2023-04-12 1:51 pm Unchanged | 13D | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 11.790% | 0 (Unchanged) | View |
| 2023-02-14 5:07 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | ORBIMED ADVISORS LLC | 0 0.000% | -5,456,780 (Position Closed) | View |
| 2023-02-14 09:58 am Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | Madison Avenue Partners LP | 7,012,226 10.400% | 364,201 (+5.48%) | View |
| 2023-02-13 4:41 pm Sale | 13G | THERAVANCE BIOPHARMA INC TBPH | BAUPOST GROUP LLC | 11,419,226 16.950% | -3,111,770 (-21.41%) | View |
| 2023-02-10 4:40 pm Purchase | 13G | THERAVANCE BIOPHARMA INC TBPH | BlackRock Inc. BLK | 5,329,830 7.900% | 327,467 (+6.55%) | View |
| 2023-02-10 4:05 pm Unchanged | 13G | THERAVANCE BIOPHARMA INC TBPH | Weiss Asset Management LP | 7,457,060 11.090% | 0 (Unchanged) | View |